Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rang in aandelen #5730
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Aandeelprijs
$29.86
Laatst gesynchroniseerd: 2026-08-19
Marktkapitalisatie
$2.48B
Verandering (1 dag)
4.92%
Verandering (1 jaar)
502.82%
Land
TW
Handel Lin BioScience, Inc. (6696)

Categorie

Koersgeschiedenis voor Lin BioScience, Inc. (6696)
Hoogste slotkoers: $26.88 op 2026-08-01

Laagste slotkoers: $1.30 op 2018-10-01
Koersgeschiedenis van Lin BioScience, Inc. van 2018 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -3.77%
2025 202.95%
2024 13.59%
2023 -31.65%
2022 -22.82%
2021 101.12%
2020 278.57%
2019 -21.27%
2018 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$543.30 39.64%
US
$1.05K 47.66%
NL
$122.63 -12.65%
AU
$144.26 474.74%
US
$761.61 6.68%
CH